HCA
HCA
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$88K
Insider Sales
16
$62.85M
Total Volume
$62.94M
17 transactions
Net Activity
$62.76M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Foster Jon M
EVP, COO
$21.69M total
Hazen Samuel N
CEO
$21.48M total
Berres Jennifer
SVP, Chief Human Res. Officer
$7.20M total
McAlevey Michael R
EVP, Chief Legal, Admin Office
$2.75M total
Cuffe Michael S.
EVP, Chief Clinical Officer
$2.35M total
Quick Actions
HCA has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. HCA ranks #98 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at HCA (HCA) engaged in a total of 17 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 16 were sales. The total volume of insider trading reached $62.94M.
The net insider activity for HCA shows a net selling bias of $62.76M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Hazen Samuel N (CEO), who traded 42.9K shares valued at $21.48M on Feb 3, 2026.
HCA Healthcare Inc. stock outperforms competitors despite losses on the day
HCA Healthcare (HCA) Stock May Be 46% Undervalued Following Cape Coral Hospital Incentives
HCA stock rebounds after dipping on financial report
Hca Holdings Stock Price Forecast. Should You Buy HCA?
HCA Healthcare (HCA) Stock Forecast and Price Target 2026
What Really Drove HCA Stock Higher?
FAQs About HCA Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for HCA.